期刊文献+

前列腺非霍奇金淋巴瘤一例报告并文献复习 被引量:5

原文传递
导出
摘要 非霍奇金淋巴瘤(non-Hodgkin lymphoma,NHL)原发部位是淋巴的网状组织,淋巴结的发生率高于结外淋巴组织[1]。泌尿生殖系统NHL发生在肾脏、肾上腺及睾丸等器官,可累及单侧或者双侧,双侧可同时发病,也可相继发病;多为转移性肿瘤,原发性的较少见,累及途径主要为血行转移和后腹膜直接侵犯[2]。泌尿生殖系统NHL约占所有NHL的10%,而侵及前列腺的低于0.1%[3]。
出处 《中华肿瘤防治杂志》 CAS 北大核心 2019年第5期345-348,共4页 Chinese Journal of Cancer Prevention and Treatment
  • 相关文献

参考文献1

二级参考文献6

  • 1Manches O,Lui G,Chaperot L,et al.In vitro mechanism of action of rituximab on primary non-Hodgkin's lymphomas.Blood,2003,101:949-954.
  • 2John C,Byrd S K,Ian W,et al.The mechanism of tumor cell Clearance by rituximab in vivo patients with B-cell chronic leukemia:evidence of caspase activation and apoptosis induction.Blood,2002,99:1038-1043.
  • 3Maloney D,Liles T,Czerwinski D,et al,Phase Ⅰ clinical trial using escalating sing-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma.Blood,1994,84:2457-2466.
  • 4Maloney D G,Grillo-Lopez A J,Bodkin D J,et al.IDEC-C2B8:Results of a phase Ⅰ multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.J Clin oncol,1997,15:3266-3274.
  • 5Coiffier B,Haioun C,Ketterer N,et al.Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma:A multicenter phase Ⅱ study.Blood,1998,92:1927-1932.
  • 6Coiffier B,Lepage E,Briere J,et al.CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma.N Engl Med,2002,346:235-242.

共引文献6

同被引文献88

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部